Management of Unstable INR on Warfarin
Introduction to Unstable INR Management
- The American College of Cardiology recommends systematically investigating and addressing reversible causes of INR variability, including medication interactions, dietary vitamin K intake, compliance issues, and alcohol use, while increasing monitoring frequency to weekly or biweekly until stability is achieved 1
Immediate Assessment and Stabilization
- For an INR of 1.2, the American College of Cardiology suggests increasing the weekly warfarin dose by 10-20% rather than making large single-dose adjustments 1
- The American College of Cardiology recommends starting doses of 4-5 mg/day in elderly patients who are more sensitive to warfarin 2, 1
- The American College of Cardiology advises resuming frequent INR monitoring at 2-4 times per week until the therapeutic range is reached and sustained for 2 consecutive days 2, 1
- The American Geriatrics Society recommends maintaining weekly to biweekly monitoring indefinitely in patients with a history of instability 3, 1
Systematic Investigation of Instability Causes
- The American College of Cardiology suggests reviewing all medications, including over-the-counter drugs and botanicals, as these are the most frequent cause of unexpected INR fluctuations 1
- The American Geriatrics Society recommends assessing for inconsistent dietary vitamin K consumption, as fluctuating intake of green leafy vegetables, certain oils, and vitamin K-containing supplements directly affects warfarin response 1
- The American College of Cardiology advises evaluating medication adherence through pill counts, pharmacy refill records, or direct questioning, as poor compliance is a common cause of INR variability 1
- The American College of Cardiology recommends screening for alcohol use, as both acute intoxication and chronic consumption affect warfarin metabolism 1
Genetic and Patient-Specific Factors
- The American College of Cardiology notes that elderly patients are inherently more sensitive to warfarin and may have greater INR variability due to polypharmacy, comorbidities, and altered drug metabolism 2, 1, 4
- The American Geriatrics Society states that advanced age (>65 years) is an independent risk factor for both bleeding complications and INR instability 3, 4
Alternative Anticoagulation Strategy
- The American College of Cardiology recommends considering switching to a direct oral anticoagulant (DOAC) if INR remains unstable despite addressing all reversible causes and optimizing monitoring 5
- DOACs offer predictable anticoagulation without need for monitoring, fewer drug-drug interactions, and no dietary restrictions 5
Critical Safety Considerations
- The American College of Cardiology emphasizes that the safety and effectiveness of warfarin depends critically on maintaining INR within therapeutic range (2.0-3.0 for most indications) 1
- The American Geriatrics Society recommends that patients maintain Time in Therapeutic Range (TTR) ≥70% for warfarin to be effective and safe 3
- The American College of Cardiology notes that risk of bleeding increases exponentially when INR exceeds 5.0, while thromboembolism risk increases when INR falls below 2.0 1